跳至主要内容
临床试验/ACTRN12622001579785
ACTRN12622001579785尚未招募未知

Magnetic Resonance Imaging Outcomes in the Colchicine After Stroke to Prevent Event Recurrence (MR CASPER): A randomized trial to examine the effect of long-term low-dose Colchicine on cerebrovascular disease progression and cognitive decline, incorporating Magnetic Resonance imaging and clinical assessments.

South Western Sydney Local Health District0 个研究点目标入组 200 人开始时间: 2022年12月21日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Eligible participants must meet the following criteria:
  • 1.Be enrolled in CASPER (ACTRN12621001408875) study
  • 2.Be aged 18 years or older
  • 3.Have recovered from an acute ischemic (non-cardioembolic) stroke without major residual disability (mRS less than or equal to 3) as per main CASPER (ACTRN12621001408875) study.
  • 4.Have a serum measurement of high sensitivity C-Reactive Protein (hs-CRP) greater than or equal to 2 mg/L at 4-52 weeks post-event as per main CASPER (ACTRN12621001408875) study.
  • 5.Be willing and able to comply with MR-CASPER sub-study visit schedule and nature of required assessments.
  • 6.Provide written informed consent for the MR CASPER sub-study.

排除标准

  • Participants that are not eligible for CASPER (ACTRN12621001408875) study will not be included.

研究者

相似试验